Other Current Assets - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33%
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epizyme Inc
Other Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Other Current Assets
$25.7m
CAGR 3-Years
22%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Current Assets
$4.7B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
6%
Gilead Sciences Inc
NASDAQ:GILD
Other Current Assets
$2.9B
CAGR 3-Years
25%
CAGR 5-Years
5%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Other Current Assets
$3B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Assets
$575.4m
CAGR 3-Years
5%
CAGR 5-Years
31%
CAGR 10-Years
33%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Assets
$681.9m
CAGR 3-Years
15%
CAGR 5-Years
27%
CAGR 10-Years
21%

See Also

What is Epizyme Inc's Other Current Assets?
Other Current Assets
25.7m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Other Current Assets amounts to 25.7m USD.

What is Epizyme Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
24%

Over the last year, the Other Current Assets growth was 27%. The average annual Other Current Assets growth rates for Epizyme Inc have been 22% over the past three years , 24% over the past five years .

Back to Top